Cholesterol Testing Market by Product Type (Test Kits, Testing Strips), Test (High-Density Lipoprotein, Low-Density Lipoprotein, Total Cholesterol Test), Test Type, Prescription Mode, End-Users - Global Forecast 2024-2030

Cholesterol Testing Market by Product Type (Test Kits, Testing Strips), Test (High-Density Lipoprotein, Low-Density Lipoprotein, Total Cholesterol Test), Test Type, Prescription Mode, End-Users - Global Forecast 2024-2030


The Cholesterol Testing Market size was estimated at USD 18.97 billion in 2023 and expected to reach USD 20.72 billion in 2024, at a CAGR 9.71% to reach USD 36.31 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cholesterol Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cholesterol Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cholesterol Testing Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Apollo Clinics, BioReference Health, LLC, Cell Biolabs, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SEKISUI Diagnostics, Siemens Healthineers AG, SpectraCell Laboratories, Inc., SYNLAB International GmbH, Thermo Fisher Scientific Inc., and Unilab Clinical Laboratory.

Market Segmentation & Coverage


This research report categorizes the Cholesterol Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Test Kits
Testing Strips
Test
High-Density Lipoprotein
Low-Density Lipoprotein
Total Cholesterol Test
Test Type
Invasive
Non-Invasive
Prescription Mode
Over the Counter
Prescription-Based
End-Users
Ambulatory Centers
Clinics
Diagnostic Centers
Homecare
Hospitals
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cholesterol Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cholesterol Testing Market?
3. What are the technology trends and regulatory frameworks in the Cholesterol Testing Market?
4. What is the market share of the leading vendors in the Cholesterol Testing Market?
5. Which modes and strategic moves are suitable for entering the Cholesterol Testing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cholesterol Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cardiovascular diseases worldwide
5.1.1.2. Proliferation in number of obese people attributed to changing eating habits
5.1.1.3. Surge in the geriatric population across the globe
5.1.2. Restraints
5.1.2.1. Availability and preference over self-testing and preference for non-invasive cholesterol tests
5.1.3. Opportunities
5.1.3.1. Favorable government and private organization campaigns to undergo regular cholesterol checkups
5.1.3.2. Robust investment in healthcare and technological advancements
5.1.4. Challenges
5.1.4.1. Strict regulatory policies in testing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cholesterol Testing Market, by Product Type
6.1. Introduction
6.2. Test Kits
6.3. Testing Strips
7. Cholesterol Testing Market, by Test
7.1. Introduction
7.2. High-Density Lipoprotein
7.3. Low-Density Lipoprotein
7.4. Total Cholesterol Test
8. Cholesterol Testing Market, by Test Type
8.1. Introduction
8.2. Invasive
8.3. Non-Invasive
9. Cholesterol Testing Market, by Prescription Mode
9.1. Introduction
9.2. Over the Counter
9.3. Prescription-Based
10. Cholesterol Testing Market, by End-Users
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Diagnostic Centers
10.5. Homecare
10.6. Hospitals
11. Americas Cholesterol Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cholesterol Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cholesterol Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. ACM Global Laboratories
15.1.2. Apollo Clinics
15.1.3. BioReference Health, LLC
15.1.4. Cell Biolabs, Inc.
15.1.5. Eurofins Scientific SE
15.1.6. F. Hoffmann-La Roche Ltd.
15.1.7. Merck KGaA
15.1.8. Quest Diagnostics Incorporated
15.1.9. Randox Laboratories Ltd.
15.1.10. SEKISUI Diagnostics
15.1.11. Siemens Healthineers AG
15.1.12. SpectraCell Laboratories, Inc.
15.1.13. SYNLAB International GmbH
15.1.14. Thermo Fisher Scientific Inc.
15.1.15. Unilab Clinical Laboratory
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. CHOLESTEROL TESTING MARKET RESEARCH PROCESS
FIGURE 2. CHOLESTEROL TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CHOLESTEROL TESTING MARKET DYNAMICS
FIGURE 7. CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 10. CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 12. CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2030 (%)
FIGURE 14. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 16. CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings